#û¶óÇѾà´ÙÀ̾îÆ®, #û¶óÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #ÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿øÇÑÀÇ¿ø, #û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, #½ÃÈïÇѾà´ÙÀ̾îÆ®
û¶óÇѾà´ÙÀ̾îÆ®,,û¶óÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,ÇѾà´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿øÇÑÀÇ¿ø,,û¶óÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø,,½ÃÈïÇѾà´ÙÀ̾îÆ®
¾È³çÇϼ¼¿ä. û¶óÇѾà´ÙÀ̾îÆ® ½ÃÈï ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
û¶óÇѾà´ÙÀ̾îÆ® ½ÃÈï Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø û¶óÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, ÇѾà´ÙÀ̾îÆ®, °Ç°ÇÑ´ÙÀ̾îÆ®, ºñ¸¸´ÙÀ̾îÆ®, Çѹæ´ÙÀ̾îÆ®, ´ÙÀ̾îÆ®, ´ÙÀ̾îƮȯ, ºñ¸¸´ÙÀ̾îÆ®, »ìºüÁö´ÂÇѾà, »ìºüÁö´ÂÇѾà, ½Ä¿å¾ïÁ¦Á¦, °Ç°ÇÑ´ÙÀ̾îÆ®, ½Ä¿å¾ïÁ¦Á¦Ã³¹æ, »êÈÄ´ÙÀ̾îÆ®, Çѹæ´ÙÀ̾îÆ®ÇѾà, ´ÙÀ̾îÆ®ÇѾàÇÑÀÇ¿ø, ½Ä¿å¾ïÁ¦Á¦Ã³¹æ, Çѹæ´ÙÀ̾îÆ®ÇѾà, ÇѾà´ÙÀ̾îÆ®, ½Ä¿å¾ïÁ¦ÇѾà, ´ÙÀ̾îÆ®, üÁú°³¼±´ÙÀ̾îÆ®, ´ÙÀ̾îÆ®ÇѾàÇÑÀÇ¿ø, Çѹæ´ÙÀ̾îÆ®ÇÑÀÇ¿ø, ´ÙÀ̾îÆ®ÇѾàµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó LASER, »ê»ï¾àħ, ³Ã¿Â¿å, silver spike point, ÀÚ¼®¿ä¹ý, ¼öÁöħ, ±â´ÉÀûÀü±âÀÚ±ØÄ¡·á, traction, üÁö¹æÃøÁ¤, ½ÉºÎÈÆÁõ°æ¶ô¾àÂò¿ä¹ý, ¾È¸éÁ¤Çüħ¼ú, ¿äõÃßÃß³ª, °æ±Ù°£¼·ÀúÁÖÆÄ, ¹è³óÄ¡·á, º¹Àâ¿îµ¿Ä¡·á, ÂÁö¾Ê´Âħġ·á, ·Ñ¸µ, EST, º¹Àâ±³Á¤Ãß³ª, ·¹ÀÌÀú, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç °¿ø Źé½Ã Å뵿, °æ±â Àǿսà ³»¼Õ1µ¿, Ãæ³² ¿¹»ê±º ´ë¼ú¸é, °æ³² Å뿵½Ã Ç׳²µ¿, °æ³² â¿ø½Ã ÀÇⱸ ÅðÃ̵¿, ºÎ»ê ºÏ±¸ ¸¸´öµ¿, °æºÏ ¼ºÁÖ±º º®Áø¸é, Àü³² ¸ñÆ÷½Ã Áßµ¿1°¡, ÃæºÏ ÃæÁֽà ±³Çö2µ¿, °æºÏ »óÁֽà ¼ºÇϵ¿, ºÎ»ê ±ÝÁ¤±¸ ºÎ°î4µ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ À屺µ¿2°¡, °æ±â ¾È¼º½Ã ¹Ì¾ç¸é, °æºÏ °í·É±º °³Áø¸é, ºÎ»ê ¼±¸ Å伺µ¿2°¡, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼¾È¾ç¿ìü±¹»ç¼ÇÔ, Àü³² °Áø±º Ä¥·®¸é, Àü³² Áøµµ±º °í±º¸é, Àü³² ¸ñÆ÷½Ã º¹¸¸µ¿, ÀÎõ Áß±¸ ¼ÛÇе¿3°¡, Àü³² ³ªÁֽà ³²ÆòÀ¾, ÀüºÏ ÀÍ»ê½Ã ¼º´ç¸é, °æºÏ ¿µÃµ½Ã ¸ÁÁ¤µ¿, ÀüºÏ ±º»ê½Ã ¹ÌÀ嵿, °¿ø Á¤¼±±º ¿©·®¸é, ºÎ»ê ¿µµµ±¸ µ¿»ïµ¿, ÀÎõ °è¾ç±¸ µÏ½Çµ¿, ºÎ»ê »ç»ó±¸ ±¥¹ýµ¿, °æ±â ½ÃÈï½Ã µµÃ¢µ¿, °æ³² ÇԾ籺 ÈÞõ¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
û¶óÇѾà´ÙÀ̾îƮġ·á ãÀ¸½Ã´Â °Ë¾Ï, ¼Ûµµ, ºñºÀ¸é, ³²±¸, »óµ¿, ³²¾çÀ¾, Áß±¸, ¼Ò·¡Æ÷±¸, µ¿Ãᵿ, ¼Ã¢µ¿, °ü±³µ¿, ¼Û»ê¸é, ÀÎõ¼±¸, ÆÈź¸é, ´ëºÎµµ, ¹®Çе¿, Á־ȿª, °è¾ç±¸, ºÀ´ãÀ¾, ¿î³²µ¿, ¿¬¼ö±¸, ¹è°ð½Åµµ½Ã, ¿µÈïµµ, ¿ëÀ¯µµ, °£¼®µ¿, ÇÐÀ͵¿, ½ÃÈï, °è»êµ¿, ¸Å¼Û¸é, ¼Û¸²µ¿, µ¿ÀÎõ, ¿î¼µ¿, À²¸ñµ¿, ½ÃÈ, µµ¸²µ¿ µî û¶ó Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿øû¶óÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129:S102.
2. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374:1677.
3. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347:f5934.
4. Arterburn DE, O'Connor PJ. A look ahead at the future of diabetes prevention and treatment. JAMA 2012; 308:2517.
5. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350:2549.
6. Leblanc ES, O'Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:434.
7. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273:219.
8. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008; 32 Suppl 7:S93.